Shipping Corporation of India Board Meeting Set for Q1 Unaudited Financial Results Approval
The Shipping Corporation of India Ltd., a Government of India enterprise engaged in transporting goods, has scheduled a meeting of its Board of Directors to approve the company's Unaudited Standalone and Consolidated Financial Results for the quarter ending June 30, 2026.The Board Meeting is set for Thursday, August 06, 2026. The primary agenda item for the meeting is to consider and subsequently approve the financial results covering the specified quarter.
In addition to the board activity, the corporation also confirmed details regarding the trading window in line with its SCI Code of Conduct for Prohibition of Insider Trading.
The trading window was closed starting July 01, 2026. It will remain closed for a period extending up to forty eight hours following the declaration of the Unaudited Standalone and Consolidated Financial Results for the quarter ended on June 30, 2026.
SCI Stock Price Movement
Shares of Shipping Corporation Of India Limited are trending up in live trading, edging to ₹280.1 at 1:14 PM after gaining 0.54% on their equity. The stock currently trades within a tight intraday range of ₹275.35 and ₹281.25, with over 622,452 shares traded so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.